Title : Identification of Novel Anthracycline Resistance Genes and Their Inhibitors.

Pub. Date : 2021 Oct 16

PMID : 34681275






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Using virtual drug screening and molecular docking analyses, we identified FDA-approved compounds (conivaptan, bexarotene, and desloratadine) that were interacting with HMOX1 and PRKCA at even stronger binding affinities than 1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethenone and ellagic acid as known inhibitors of HMOX1 and PRKCA, respectively. Bexarotene heme oxygenase 1 Homo sapiens
2 Using virtual drug screening and molecular docking analyses, we identified FDA-approved compounds (conivaptan, bexarotene, and desloratadine) that were interacting with HMOX1 and PRKCA at even stronger binding affinities than 1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethenone and ellagic acid as known inhibitors of HMOX1 and PRKCA, respectively. Bexarotene heme oxygenase 1 Homo sapiens
3 Bexarotene treatment had a comparable doxorubicin-sensitizing effect in HMOX1-transfected cells and desloratadine in PRKCA-transfected cells. Bexarotene heme oxygenase 1 Homo sapiens